Fairmount Funds Management’s Terns Pharmaceuticals TERN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-748,996
| Closed | -$5.1M | – | 17 |
|
|
2024
Q2 | $5.1M | Sell |
748,996
-1,291,004
| -63% | -$8.79M | 0.58% | 13 |
|
|
2024
Q1 | $13.4M | Hold |
2,040,000
| – | – | 1.46% | 15 |
|
|
2023
Q4 | $13.2M | Hold |
2,040,000
| – | – | 1.4% | 15 |
|
|
2023
Q3 | $10.3M | Hold |
2,040,000
| – | – | 1.23% | 18 |
|
|
2023
Q2 | $17.9M | Hold |
2,040,000
| – | – | 2.52% | 10 |
|
|
2023
Q1 | $24.2M | Hold |
2,040,000
| – | – | 4.15% | 10 |
|
|
2022
Q4 | $20.8M | Sell |
2,040,000
-10,000
| -0.5% | -$102K | 3.29% | 11 |
|
|
2022
Q3 | $12.1M | Buy |
+2,050,000
| New | +$12.1M | 2.12% | 17 |
|